Lindbrook Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
EIP
BTW
Lindbrook Capital's AMPH Position: Q1 2025 in Review
Lindbrook Capital increased its Amphastar Pharmaceuticals (AMPH) stake by 287% in Q1 2025, buying an estimated $4.95K and bringing the position to 209 shares worth $6.06K. The position accounts for ﹤0.01% of the portfolio, ranked #1876.
Lindbrook Capital first reported a position in AMPH in Q1 2020 and has held it in 21 quarters since. 241 funds tracked by Wall St. Rank hold AMPH as of Q1 2025.
- Lindbrook Capital held 209 shares of Amphastar Pharmaceuticals worth $6.06K as of Q1 2025.
- Lindbrook Capital bought 155 Amphastar Pharmaceuticals shares in Q1 2025, an estimated $4.95K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1876 holding.
- Lindbrook Capital first reported a position in Amphastar Pharmaceuticals in Q1 2020 and has held it in 21 quarters since.
- 241 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.